Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationships

Structure-activity relationships around a novel series of B-Raf(V600E) inhibitors are reported. The enzymatic and cellular potencies of inhibitors derived from two related hinge-binding groups were compared and3-methoxypyrazolopyridine proved to be superior. The 3-alkoxy group of lead B-Raf(V600E) inhibitor 1 was extended and minimally affected potency. The propyl sulfonamide tail of compound 1, which occupies the small lipophilic pocket formed by an outward shift of the αC-helix, was expanded to a series of arylsulfonamides. X-ray crystallography revealed that this lipophilic pocket unexpectedly enlarges to accommodate the bulkier aryl group.     

The Luoping biota: exceptional preservation, and new evidence on the Triassic recovery from end-Permian mass extinction

The timing and nature of biotic recovery from the devastating end-Permian mass extinction (252 Ma) are much debated. New studies in South China suggest that complex marine ecosystems did not become re-established until the middle–late Anisian (Middle Triassic), much later than had been proposed by some. The recently discovered exceptionally preserved Luoping biota from the Anisian Stage of the Middle Triassic, Yunnan Province and southwest China shows this final stage of community assembly on the continental shelf. The fossil assemblage is a mixture of marine animals, including abundant lightly sclerotized arthropods, associated with fishes, marine reptiles, bivalves, gastropods, belemnoids, ammonoids, echinoderms, brachiopods, conodonts and foraminifers, as well as plants and rare arthropods from nearby land. In some ways, the Luoping biota rebuilt the framework of the pre-extinction latest Permian marine ecosystem, but it differed too in profound ways. New trophic levels were introduced, most notably among top predators in the form of the diverse marine reptiles that had no evident analogues in the Late Permian. The Luoping biota is one of the most diverse Triassic marine fossil Lagerstätten in the world, providing a new and early window on recovery and radiation of Triassic marine ecosystems some 10 Myr after the end-Permian mass extinction.     

新型糖基化酶AlkC和AlkD

DNA糖基化酶是一类有着重要生物功能的蛋白质,广泛存在于原核生物和真核生物中。研究表明,DNA糖基化酶能够特异性地识别损伤碱基,再通过各种酶修复DNA。最近,科学家在筛选土壤中3-甲基腺嘌呤糖基化酶时,发现了三种基因AlkC、AlkD和AlkE,其中AlkC和AlkD是两种新基因。本文根据近年来的研究成果,对AlkC和AlkD两种碱基糖基化修复酶的结构和功能,以及AlkD的切除损伤DNA的核酸捕获机理进行了总结。     

高温胁迫下五种杜鹃花属植物的生理变化及其耐热性比较

高温是制约分布于较高海拔地区杜鹃花迁地保育与园林应用的重要因子.为探讨杜鹃花属植物的 高温致伤机理,该实验以隶属不同亚属的白花杜鹃、羊踯躅、毛棉杜鹃、红滩杜鹃及红棕杜鹃4年生实生苗为 材料,通过人工气候箱的盆栽实验,研究了30℃、38℃高温胁迫下其叶片生理生化指标的变化,并利用隶属 函数法及系统聚类分析法对其种间...     

眼皮肤白化病患者酪氨酸酶基因突变的研究

目的：对临床诊断为眼皮肤白化病（OCA）患者的酪氨酸酶（TYR）基因进行突变筛查,了解我国大陆OCA患者TYR基因突变类型,探讨基因突变对人TYR蛋白结构和功能的影响。方法：应用PCR技术,扩增患者及其父母的TYR基因外显子、外显子-内含子交界区及启动子区;以DNA序列测定技术,进行突变筛查与鉴定;利用生物信息学方法,对突变引起蛋白结构和功能的改变进行预测与分析。结果：在15名患者的30个TYR等位基因内,查明11种突变;其中错义突变5种（W400L、R299H、E294K、R77Q和K142M）,无义突变3种（R116X、R278X和G295X）,插入突变2种（929insC和232insGGG）,剪切位点突变1种（IVS1-3 C〉G）;对4个突变W400L、R299H、929insC、232insGGG的生物信息学分析显示,突变的致病性与蛋白结构和功能的改变相关。结论：W400L占本研究所检出全部OCA1突变等位基因的30．0％（9／30）,可能为中国大陆人群中较常见的TYR基因突变类型;应用生物信息学分析方法对TYR基因突变的致病性做出一些合理可能的解释是可行的。     

麋鹿人工授精技术初步研究

为了为麋鹿的人工繁殖提供理论基础,2007年7月～2009年6月对麋鹿人工授精技术进行了研究.2007年7月,对5只雄性麋鹿进行了6次电刺激采精试验,成功率100%(6/6),采得的精液品质优良,采精量为0.7～4.0 mL,平均采精量(1.7±1.3)mL,平均精子密度(14.25±2.88)亿/mL,精子活力为50%～80%.2007年,应用孕激素类药物(CIDR)对6只雌鹿进行同期发情处理,采用定时1次人工输精,鲜精输精6只,受胎1只,受胎率为16.7%;2008年,5只雌鹿发情采用雄鹿试情,冻精输精5只,受胎1只,受胎率20%.这两只麋鹿孕期分别为288 d和268 d.     

湖北西部山地革螨及恙螨名录

自1989年以来,先后从湖北西部山地6个不同海拔、12个不同类型生境捕获的啮齿、食虫等小型哺乳动物体外采集到一大批革螨、恙螨和吸虱标本,经初步整理,鉴定有革螨l1科32属73种、恙螨有3亚科11属41种和亚种、吸虱3种,其中有中国新纪录1种,籁氏巨刺螨Macronyssus leucippe（Domrow）和湖北新纪录41种。     

虎耳草石油醚提取物的化学成分分析

目的:对虎耳草微波辅助-石油醚提取物的化学成分进行研究。方法:采用气相色谱-质谱-数据系统联用技术对虎耳草微波辅助-石油醚提取物的化学成分进行分析鉴定。结果:石油醚提取物共鉴定出102种成分。结论:采用气相色谱-质谱-数据系统联用技术能够对低极性部位的化学成分快捷、简便、准确分析。     

2010年宜昌市铜绿假单胞菌的耐药性分析

了解宜昌市铜绿假单胞菌（Pseudomonas aeruginosa）临床分离株的耐药现状。宜昌市城区5所医院临床分离的铜绿假单胞菌菌株,用K-B法作药敏试验,并根据统计其耐药情况及耐药表型（模式）分析可能存在的耐药机制。临床分离的铜绿假单胞菌共1 575株,耐药率依次为阿米卡星7.1%、美罗培南17.2%、头孢吡肟20.4%、头孢哌酮/舒巴坦21.0%、哌拉西林/他唑巴坦22.5%、环丙沙星23.1%、庆大霉素23.4%、头孢他啶25.0%、亚胺培南25.2%、哌拉西林30.4%、氨曲南34.5%、复方新诺明59.0%、米诺环素75.6%。多重耐药（MDR）和泛耐药（PDR）株分别占41.5%和0.17%。对各种抗假单胞菌药物分别耐药的菌株仍有13%～25.7%对阿米卡星敏感,提示在严重铜绿假单胞菌感染患者的治疗中,β内酰胺类抗假单胞菌药加氨基糖苷类仍是一个很好的联合用药组合。细菌耐药性仍呈增长趋势,临床上感染多重耐药和泛耐药的铜绿假单胞菌的治疗仍很棘手,应合理使用抗生素,尽量延缓耐药菌株的出现。